FDA Grants Accelerated Approval to Sunvozertinib for Metastatic Non-Small Cell Lung Cancer with EGFR exon 20 Insertion Mutations By Ogkologos - July 25, 2025 246 0 Facebook Twitter Google+ Pinterest WhatsApp FDA also approved the Oncomine Dx Express Test as a companion diagnostic device Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Generic Palbociclib Metastasis-Directed Therapy for Oligometastatic Solid Tumours in Histology-Specific Context ctDNA Testing After Neoadjuvant Chemotherapy and Radical Cystectomy Predicts Recurrence Risk in Patients with MIBC MOST POPULAR New on NCI’s Websites for September 2023 September 29, 2023 Breast-Cancer Mom Is Living On 84 Pence As She Fights For... April 15, 2019 Dad With Cancer Escorts His Autistic Son To School, With The... August 13, 2019 Approval of Elahere Expands Treatment Options for Some Advanced Ovarian Cancers April 24, 2024 Load more HOT NEWS Honeybee Venom May Be the Next Treatment for Aggressive Breast Cancer FDA Approves Selinexor for Refractory or Relapsed Multiple Myeloma Atezolizumab Approved for Initial Treatment of Metastatic Lung Cancer Making Transformative Advances against Childhood Cancer: A Conversation with Dr. Doug...
